MDXG compared with BVS: revenue, margins and what each company keeps, and the suppliers and customers both name

MDXGMimedx Group, Inc.

Mkt capRevenueRevenue

BVSBioventus Inc.

Mkt capRevenueRevenue

Compare

MDXGMimedx Group, Inc.

BVSBioventus Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only MDXG 4

TTRXTurn Therapeuticssupplier

—Regenity Biosciencesunlistedsupplier

—Regen Lab USAunlistedsupplier

—Gunze Medicalunlistedcustomer

Shared 0

No shared counterparties.

Only BVS 1

—Apex Biologixunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

MDXGMimedx Group, Inc.

3.19▼−2.78%

Mkt cap$478.6MRevenue$62MQ3 FY26Revenue$419MFY25

BVSBioventus Inc.

10.65▼−19.03%

Regular sessionNov 3 '26

Mkt cap$1.1BRevenue$142MQ3 FY26Revenue$568MFY25

Compare

Regular sessionNov 3 '26

MDXGMimedx Group, Inc.

BVSBioventus Inc.

3.19▼−2.78%

Price

10.65▼−19.03%

$478.6M

Mkt cap

$1.1B

Q3 FY26$62M

Revenue

$142MQ3 FY26

FY25$419M

Revenue

$568MFY25

MDXG3.19▼−2.78%vsBVS10.65▼−19.03%Regular sessionNov 3 '26